...
search icon
rvmd-img

Revolution Medicines Inc Share Price

RVMD
NSQ
$96.31
-$1.02
(-1.05%)
1D
Industry: Biotechnology Sector: Health Care

Revolution Medicines Inc Analyst Forecast

Revolution Medicines Inc Share Price Chart

Revolution Medicines Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$18.82B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.59M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.00
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$29.17 L
$124.49 H
$96.31

About Revolution Medicines Inc, Common Stock

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California. more

Industry: BiotechnologySector: Health Care

Revolution Medicines Inc Stock Returns

Time FrameRVMDSectorS&P500
1-Week Return-1.21%-1.08%-1.38%
1-Month Return-19.71%-0.47%-1.81%
3-Month Return49.6%2.13%1.38%
6-Month Return167.01%17.04%5.68%
1-Year Return133.08%6.56%11.74%
3-Year Return277.09%16.78%65.15%
5-Year Return101.53%34.34%73.68%
10-Year Return233.25%137.88%260.03%

Revolution Medicines Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue42.98M29.39M35.38M11.58M-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":68.38,"profit":true},{"date":"2022-12-31","value":82.31,"profit":true},{"date":"2023-12-31","value":26.94,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue132.25M186.95M253.07M411.24M592.23M[{"date":"2020-12-31","value":22.33,"profit":true},{"date":"2021-12-31","value":31.57,"profit":true},{"date":"2022-12-31","value":42.73,"profit":true},{"date":"2023-12-31","value":69.44,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit42.98M29.39M35.38M11.58M(592.23M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":68.38,"profit":true},{"date":"2022-12-31","value":82.31,"profit":true},{"date":"2023-12-31","value":26.94,"profit":true},{"date":"2024-12-31","value":-1377.81,"profit":false}]
Gross Margin100.00%100.00%100.00%100.00%-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses153.68M217.40M293.66M498.76M689.52M[{"date":"2020-12-31","value":22.29,"profit":true},{"date":"2021-12-31","value":31.53,"profit":true},{"date":"2022-12-31","value":42.59,"profit":true},{"date":"2023-12-31","value":72.33,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(110.70M)(188.01M)(258.28M)(487.19M)(689.52M)[{"date":"2020-12-31","value":-11069700000,"profit":false},{"date":"2021-12-31","value":-18800800000,"profit":false},{"date":"2022-12-31","value":-25827900000,"profit":false},{"date":"2023-12-31","value":-48718500000,"profit":false},{"date":"2024-12-31","value":-68952400000,"profit":false}]
Total Non-Operating Income/Expense4.33M1.83M18.31M94.47M175.56M[{"date":"2020-12-31","value":2.47,"profit":true},{"date":"2021-12-31","value":1.04,"profit":true},{"date":"2022-12-31","value":10.43,"profit":true},{"date":"2023-12-31","value":53.81,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(108.53M)(187.09M)(249.13M)(439.89M)(600.85M)[{"date":"2020-12-31","value":-10853000000,"profit":false},{"date":"2021-12-31","value":-18709100000,"profit":false},{"date":"2022-12-31","value":-24912500000,"profit":false},{"date":"2023-12-31","value":-43989100000,"profit":false},{"date":"2024-12-31","value":-60084600000,"profit":false}]
Income Taxes(371.00K)(7.32M)(420.00K)(3.52M)(753.00K)[{"date":"2020-12-31","value":-37100000,"profit":false},{"date":"2021-12-31","value":-732000000,"profit":false},{"date":"2022-12-31","value":-42000000,"profit":false},{"date":"2023-12-31","value":-352400000,"profit":false},{"date":"2024-12-31","value":-75300000,"profit":false}]
Income After Taxes(108.16M)(179.77M)(248.71M)(436.37M)(600.09M)[{"date":"2020-12-31","value":-10815900000,"profit":false},{"date":"2021-12-31","value":-17977100000,"profit":false},{"date":"2022-12-31","value":-24870500000,"profit":false},{"date":"2023-12-31","value":-43636700000,"profit":false},{"date":"2024-12-31","value":-60009300000,"profit":false}]
Income From Continuous Operations(108.16M)(187.09M)(248.71M)(436.37M)(600.09M)[{"date":"2020-12-31","value":-10815900000,"profit":false},{"date":"2021-12-31","value":-18709100000,"profit":false},{"date":"2022-12-31","value":-24870500000,"profit":false},{"date":"2023-12-31","value":-43636700000,"profit":false},{"date":"2024-12-31","value":-60009300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(108.16M)(187.09M)(248.71M)(436.37M)(600.09M)[{"date":"2020-12-31","value":-10815900000,"profit":false},{"date":"2021-12-31","value":-18709100000,"profit":false},{"date":"2022-12-31","value":-24870500000,"profit":false},{"date":"2023-12-31","value":-43636700000,"profit":false},{"date":"2024-12-31","value":-60009300000,"profit":false}]
EPS (Diluted)(2.14)(2.56)(3.10)(3.77)(3.57)[{"date":"2020-12-31","value":-214,"profit":false},{"date":"2021-12-31","value":-256,"profit":false},{"date":"2022-12-31","value":-310,"profit":false},{"date":"2023-12-31","value":-377,"profit":false},{"date":"2024-12-31","value":-357,"profit":false}]

Revolution Medicines Inc Ratios

Revolution Medicines Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

RVMD
Cash Ratio 7.86
Current Ratio 8.05

Revolution Medicines Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RVMD
ROA (LTM) -32.29%
ROE (LTM) -60.76%

Revolution Medicines Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RVMD
Debt Ratio Lower is generally better. Negative is bad. 0.29
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.71

Revolution Medicines Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RVMD
Trailing PE NM
Forward PE NM
P/S (TTM) 9035.10
P/B 11.78
Price/FCF NM
EV/R 8370.02
EV/Ebitda NM

FAQs

What is Revolution Medicines Inc share price today?

Revolution Medicines Inc (RVMD) share price today is $96.31

Can Indians buy Revolution Medicines Inc shares?

Yes, Indians can buy shares of Revolution Medicines Inc (RVMD) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RVMD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Revolution Medicines Inc be purchased?

Yes, you can purchase fractional shares of Revolution Medicines Inc (RVMD) via the Vested app. You can start investing in Revolution Medicines Inc (RVMD) with a minimum investment of $1.

How to invest in Revolution Medicines Inc shares from India?

You can invest in shares of Revolution Medicines Inc (RVMD) via Vested in three simple steps:

  • Click on Sign Up or Invest in RVMD stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Revolution Medicines Inc shares
What is Revolution Medicines Inc 52-week high and low stock price?

The 52-week high price of Revolution Medicines Inc (RVMD) is $124.49. The 52-week low price of Revolution Medicines Inc (RVMD) is $29.17.

What is Revolution Medicines Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Revolution Medicines Inc (RVMD) is

What is Revolution Medicines Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Revolution Medicines Inc (RVMD) is 11.78

What is Revolution Medicines Inc dividend yield?

The dividend yield of Revolution Medicines Inc (RVMD) is 0.00%

What is the Market Cap of Revolution Medicines Inc?

The market capitalization of Revolution Medicines Inc (RVMD) is $18.82B

What is Revolution Medicines Inc's stock symbol?

The stock symbol (or ticker) of Revolution Medicines Inc is RVMD

How Can Investors Use Revolution Medicines Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Revolution Medicines Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Revolution Medicines Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Revolution Medicines Inc shares for Indian investors?

When investing in Revolution Medicines Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Revolution Medicines Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Revolution Medicines Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Revolution Medicines Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Revolution Medicines Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top